These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16475689)

  • 21. Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.
    Ray A; Naik SL; Sharma BK
    Indian J Physiol Pharmacol; 2002 Oct; 46(4):423-33. PubMed ID: 12683217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR LI and Ki-67 LI are independent prognostic parameters influencing survivals of surgically treated squamous cell lung cancer patients.
    Niemiec J; Kolodziejski L; Dyczek S
    Neoplasma; 2005; 52(3):231-7. PubMed ID: 15875085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
    Katori H; Nozawa A; Tsukuda M
    Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
    Liu D; Nakano J; Ishikawa S; Yokomise H; Ueno M; Kadota K; Urushihara M; Huang CL
    Lung Cancer; 2007 Dec; 58(3):384-91. PubMed ID: 17728005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of c-erbB-2 oncoprotein and associated pathobiological factors in invasive primary breast cancer.
    Ray A; Sharma BK; Kaur S; Sharma S; Sharma JK
    Indian J Exp Biol; 2004 Mar; 42(3):253-8. PubMed ID: 15233293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
    Jung CK; Jung JH; Park GS; Lee A; Kang CS; Lee KY
    Pathol Int; 2006 Sep; 56(9):503-9. PubMed ID: 16930330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative prognostic impact of the coexpression of epidermal growth factor receptor and c-erbB-2 in locally advanced cervical cancer.
    Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Mendiola C; Alonso L; Alba E; Lanzós E
    Oncology; 2009; 76(2):133-41. PubMed ID: 19174612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC).
    Karg A; Dinç ZA; Başok O; Uçvet A
    Pathol Res Pract; 2006; 202(8):577-83. PubMed ID: 16814944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
    Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.
    Na II; Rho JK; Choi YJ; Kim CH; Park JH; Koh JS; Ryoo BY; Yang SH; Lee JC
    Lung Cancer; 2007 Jul; 57(1):96-102. PubMed ID: 17337084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
    Liao DW; Wang L; Zhang XG; Liu MQ
    Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.
    Hernes E; Fosså SD; Berner A; Otnes B; Nesland JM
    Br J Cancer; 2004 Jan; 90(2):449-54. PubMed ID: 14735192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
    Sonobe M; Nakagawa M; Takenaka K; Katakura H; Adachi M; Yanagihara K; Otake Y; Wada H; Tanaka F
    J Surg Oncol; 2007 Jan; 95(1):63-9. PubMed ID: 17192868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic gliomas.
    von Bossanyi P; Sallaba J; Dietzmann K; Warich-Kirches M; Kirches E
    Pathol Res Pract; 1998; 194(3):141-7. PubMed ID: 9587931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of vascular endothelial growth factor C and cyclooxygenase-2 in non-small-cell lung carcinoma and their clinical significance].
    Zhang HZ; Hua P; Li HG; Lü ZQ; Zeng YJ; Liu JG; Zeng H
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):734-7. PubMed ID: 16483484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
    Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
    Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.